P
PYC
PYC THERAPEUTICS
1.405
+0.025+1.81%Opening14:36 05/27 AEST
OPEN/PREV CLOSE1.370/1.380
TODAY RANGE1.365-1.425
VOL1.13M
MARKET CAP1.38B
52 WEEK RANGE0.828-1.755
AVG VOL (3M)2.26M
% TURNOVER0.11%
TURNOVER1.58M
P/E (TTM)-16.8062
% RANGE4.35%
EPS(TTM)-0.0836
P/E(FORWARD)-19.5139
P/B5.70
BVPS0.246
DIVIDEND--
P/S32.22
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP995.74M
SHARES OUTSTANDING983.51M
NEXT EARNINGS08/26-08/31
FREE FLOAT708.71M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·19h ago
Change to CEO remuneration-PYC.AX
ASX·05/18 09:06
Ceasing to be a substantial holder-PYC.AX
ASX·05/11 23:07
Investor Webinar
ASX·05/11 08:56
Notification of cessation of securities - PYC
ASX·05/06 23:05
PKD - Initiation of Multiple Dose Clinical Trial
ASX·05/03 23:17
Presentation of Ophthalmology Clinical Trial Data at ARVO
ASX·04/28 08:46
Exercise of Options and Cleansing Notice
ASX·04/28 08:36
Application for quotation of securities - PYC
ASX·04/28 00:00
PYC Therapeutics Ltd Prelim Q3
ASX·04/26 23:50
Orphan Drug Designation Granted for RP11 by EMA
The Motley Fool·04/21 05:13
This ASX biotech stock could more than double Canaccord Genuity says
The Motley Fool·04/15 02:44
This ASX biotech stock just jumped again as its lead drug trial moves ahead
ASX·04/15 00:53
ADOA Program - SRC Approve Progression to Multi-Dose Study
Dow Jones·04/14 22:51
*PYC Therapeutics Target Price Cut 0.4% to A$2.84/Share by Canaccord Genuity>PYC.AU
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others